Aiolos Bio debuts with $245 million financing | The Pharmaletter
Oct 24, 2023 · San Francisco, USA-based biotech start-up Aiolos Bio has today emerged out of stealth, backed by an oversubscribed $245 million Series A investment. The company said the …
OFF
Aiolos Bio Debuts With $245 Million Financing | The Pharmaletter
2 days from now
Oct 24, 2023 · San Francisco, USA-based biotech start-up Aiolos Bio has today emerged out of stealth, backed by an oversubscribed $245 million Series A investment. The company said the …
thepharmaletter.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Oct 24, 2023 · Aiolos launches with an oversubscribed $245 million Series A investment co-led by Atlas Venture, Bain Capital Life Sciences, Forbion, and Sofinnova Investments with additional …
businesswire.com
OFF
Forbion Co-leads $245 Million Series A Financing Of Aiolos
2 days from now
Oct 24, 2023 · SAN FRANCISCO AND LONDON – October 24, 2023 - Forbion, a leading European life sciences venture capital firm, today announces that it has co-led a $245 million …
forbion.com
OFF
Aiolos Bio Raises $245M On Prospect Of Better Asthma Drug
2 days from now
Oct 24, 2023 · Aiolos Bio raises $245M on prospect of better asthma drug ... A new biotechnology company has raised $245 million in a Series A financing round on the promise of an asthma …
biopharmadive.com
OFF
Aiolos $245m Series A Heads Latest Crop Of Biotech Rounds
2 days from now
3 days ago · A new US biotech, Aiolos Bio, has drawn in an impressive $245 million in Series A financing that will help it complete clinical testing of lead drug AIO-001 for moderate-to-severe …
pharmaphorum.com
OFF
Aiolos Raises $245 Million; Partners Hengrui’s Asthma Drug In $1 ...
2 days from now
Oct 24, 2023 · San Francisco's Aiolos Bio, a respiratory and inflammatory drug company, broke cover with $245 million in Series A funds and a Phase II asthma drug in-licensed from Jiangsu …
chinabiotoday.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody. Share This Article • Developing a potentially best-in-class …
vcaonline.com
OFF
Aiolos Bio Raises $250M For Severe Asthma Drug - Pharmtales.com
2 days from now
Oct 24, 2023 · Aiolos Bio debuts with $250M and ex-Gyroscope CEO to tackle severe asthma. ... This theme is further exemplified by the emergence of Aiolos Bio from stealth mode, fueled by …
pharmtales.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To
2 days from now
Oct 24, 2023 · Developing a potentially best-in-class TSLP antibody (AIO-001) that is dosed every 6-months for patients with respiratory and inflammatory conditions Khurem Farooq, Co …
benzinga.com
OFF
Aiolos Bio Launches With $245M Series A - Jacobsmgt.com
2 days from now
San Francisco & London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. has launched as a clinical-stage biopharmaceutical company that aims to address the unmet respiratory and …
jacobsmgt.com
OFF
Series A - Aiolos Bio - 2023-10-24 - Crunchbase
2 days from now
Oct 24, 2023 · Aiolos Bio raised $245000000 on 2023-10-24 in Series A. Search Crunchbase. ... BioSpace — Aiolos Bio Launches with $245 Million Series A Investment to Advance …
crunchbase.com
OFF
Aiolos Bio Launches With Ex-Gyroscope CEO At The Helm, Nearly …
2 days from now
Jan 16, 2024 · Aiolos Bio is jetting out of stealth with a $245 million series A, igniting its startup thrusters en route to a phase 2 trial for its lead asset to treat severe asthma. That asset, AIO …
biotech-today.com
OFF
Aiolos Bio Raises $245M In Series A Funding - FinSMEs
2 days from now
Oct 25, 2023 · Aiolos Bio, a San Francisco, CA-based clinical-stage biopharmaceutical company, raised $245M in Series A funding. The round was led by Atlas Venture, Bain Capital Life …
finsmes.com
OFF
Startup Launches With $245M For Twice Yearly Asthma Treatment
2 days from now
Oct 24, 2023 · A new biotech has raised $245 million to test a new asthma medication that could compete with one sold by Amgen and AstraZeneca.. The startup, Aiolos Therapeutics, was …
statnews.com
OFF
JPM 2024: GSK Buys Aiolos Bio For $1.4 Billion, Cytokinetics ...
2 days from now
Jan 10, 2024 · Aiolos Won GSK’s Favor in Less Than 3 Months After Launch Launched in October 2023 with an oversubscribed $245 million Series A investment, Aiolos Bio is a clinical …
geneonline.com
FAQs about Aiolos Bio debuts with $245 million financing | The Pharmaletter Coupon?
Who invested in Aiolos?
Why did Aiolos bio invest $245 million in series a funds?
Is Aiolos bio launching a new asthma drug?
Is Aiolos a good investment for a biotech?
What is Aiolos bio?
Who owns Aiolos bio?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
